Research Grade Anti-B7-H3 & EGFR Bispecific Antibody (Ibi-334)Anti-B7-H3 & EGFR Bispecific Antibody (Ibi-334) ( HV612086 ) is a research-grade recombinant antibody targeting CD276 . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. Спецификация| Species reactivity | Human | | Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo | | Form | Liquid | | Storage | -20℃ | | Product category | Bispecific Antibodies | | Target | CD276 antigen, 4Ig-B7-H3, B7 homolog 3, B7-H3, Costimulatory molecule, CD276, CD276, Epidermal growth factor receptor, EC:2.7.10.1, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, EGFR | | Accession | Q5ZPR3 & P00533 | | Host species | Human | | | |
Информация для заказа| Область использования: | Производство: | Puda Scientific | | Метод: | Иммуногистохимия | | Объем: | 1mg | | Кат. номер: | PD-A26-15521-100 | | Цена (с НДС 22%): | по запросу | В корзину  | Наименование: Research Grade Anti-B7-H3 & EGFR Bispecific Antibody (Ibi-334).
Примечание: |
|
